Review: Barrett's esophagus and the increasing role of endoluminal therapy

Michael S. Smith, Charles J. Lightdale

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Barrett's esophagus, or the presence of specialized intestinal mucosa in the esophagus that has a malignant potential, has experienced a rapid increase in diagnosis and prevalence over the past few decades. Once thought to progress to adenocarcinoma in an orderly sequence of increasing dysplasia, recent data suggest the process can be more random. In combination with targeted surveillance endoscopy, recent improvements in technology have aided endoluminal therapy in becoming a cost-effective adjunct to medication. When used in combination, in particular, these ablative therapies have become suitable, if not preferable, alternatives to surgery in many patients.

Original languageEnglish
Pages (from-to)121-142
Number of pages22
JournalTherapeutic Advances in Gastroenterology
Issue number2
StatePublished - Sep 2008
Externally publishedYes


  • Barrett's esophagus
  • esophageal cancer
  • gastro-esophageal reflux disease


Dive into the research topics of 'Review: Barrett's esophagus and the increasing role of endoluminal therapy'. Together they form a unique fingerprint.

Cite this